{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:18:03Z","timestamp":1783703883712,"version":"3.55.0"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRCEP"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Botulinum toxin injections, a popular aesthetic treatment, have over 7.4 million beneficiaries\nin the U.S. Despite their safety record, these injections pose potential complications. It is essential\nfor aesthetic practitioners to manage these complications with the least impact on the patient.\nUpper eyelid ptosis, though rare, is a significant side effect of botulinum toxin injections.\nThrough our study, we have identified the etiology, anatomy, and therapeutic management of botulinum-\ninduced blepharoptosis. Hence, the goal of this study was to identify the basic aetiology\nof blepharoptosis and manage this complication, as well as discuss the basis of medico-legal implications\ninvolving this popular drug. The complex medico-legal implications of botulinum toxin-induced\nblepharoptosis call for continuous discourse, education, and clarity on drug-use legal standards.\nWith evolving global and Italian legislation, practitioners must ensure they meet care standards,\nweighing treatment benefits against potential legal and ethical outcomes. Blepharoptosis is\na rare but significant complication of botulinum-type injections. Etiology and thorough anatomy\nare crucial for avoiding this complication and handling it with the least impact on the patient.\nMedico-legal implications are currently not fully established, but the basis of aesthetic treatment\nstandards, as well as continuing medical education, will ensure correct medico-legal coverage of\nsuch complications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0127724328310459240809073519","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T06:04:42Z","timestamp":1724133882000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anatomy, Etiology, Management, and Medico-Legal Implications of Botulinum-induced Blepharoptosis"],"prefix":"10.2174","volume":"20","author":[{"given":"Giulio","family":"Nittari","sequence":"first","affiliation":[{"name":"Telemedicine and Telepharmacy Centre, School of Medicinal and Health Products Sciences, University of Camerino, Camerino, 62032, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4757-1527","authenticated-orcid":true,"given":"Demetris","family":"Savva","sequence":"additional","affiliation":[{"name":"Plastic, Reconstructive and Aesthetic Surgery, Nicosia General Hospital, Nicosia, 2031,\nCyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Gibelli","sequence":"additional","affiliation":[{"name":"Section of Legal Medicine, School of Law, University of Camerino, Camerino, 62032, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vulcanescu","sequence":"additional","affiliation":[{"name":"General\nMedicine, Nicosia General Hospital, Nicosia 2031, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"De Leo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Public Health, Section of\nForensic Medicine, University of Verona, Verona, 36134, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Ricci","sequence":"additional","affiliation":[{"name":"Section of Legal Medicine, School of Law, University of Camerino, Camerino, 62032, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Mizuho Securities H.C.","year":"2021","unstructured":"Mizuho Securities H.C.; AEON BIOPHARMA  Available from:  https:\/\/www.sec.gov\/Archives\/edgar\/data\/1622667\/000156 459021049917\/aeon-s1a.htm Last accessed on 21 September 2023.2021"},{"key":"ref=2","year":"2023","unstructured":"Key facts about Botox  Available from:  https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/botox#key-facts-section Last accessed on 21 September 2023.2023","journal-title":"Key facts about Botox"},{"key":"ref=3","year":"2002","unstructured":"Annual report pursuant to section 13 or 15(d) of the securities exchange act of 1934.  Available from:  https:\/\/www.sec.gov\/files\/form10-k.pdf2002"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/toxins13070494","volume":"13","author":"Kaufman-Janette J.","year":"2021","unstructured":"Kaufman-Janette J.; Cox S.E.; Dayan S.; Joseph J.; Botulinum toxin type A for glabellar frown lines: What impact of higher doses on outcomes? Toxins  2021,13(7),494","journal-title":"Toxins"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083259","volume":"53","author":"Dressler D.","year":"2005","unstructured":"Dressler D.; Adib Saberi F.; Botulinum toxin: Mechanisms of action. Eur Neurol  2005,53(1),3-9","journal-title":"Eur Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/jocd.13266","volume":"19","author":"Kassir M.","year":"2020","unstructured":"Kassir M.; Gupta M.; Galadari H.; Kroumpouzos G.; Katsambas A.; Lotti T.; Vojvodic A.; Grabbe S.; Juchems E.; Goldust M.; Complications of botulinum toxin and fillers: A narrative review. J Cosmet Dermatol  2020,19(3),570-573","journal-title":"J Cosmet Dermatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1097\/01.PRS.0000076504.79727.62","volume":"112","author":"Carruthers J.D.","year":"2003","unstructured":"Carruthers J.D.; Lowe N.J.; Menter M.A.; Gibson J.; Eadie N.; Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg  2003,112(4),21S-30S","journal-title":"Plast Reconstr Surg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s00266-008-9199-6","volume":"32","author":"Harii K.","year":"2008","unstructured":"Harii K.; Kawashima M.; A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. Aesthetic Plast Surg  2008,32(5),724-730","journal-title":"Aesthetic Plast Surg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.asj.2009.09.010","volume":"29","author":"Rubin M.","year":"2009","unstructured":"Rubin M.; Dover J.; Maas C.; Nestor M.; An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesthet Surg J  2009,29(6)(Suppl.),S50-S56","journal-title":"Aesthet Surg J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1524-4725.2009.01390.x","volume":"36","author":"Wu Y.","year":"2010","unstructured":"Wu Y.; Zhao G.; Li H.; Zheng Z.; Zhong S.; Yang Z.; Feng Z.; Yang Q.; Zhu X.; Botulinum toxin type A for the treatment of glabellar lines in Chinese: A double-blind, randomized, placebo-controlled study. Dermatol Surg  2010,36(1),102-108","journal-title":"Dermatol Surg"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","volume":"33","author":"Monheit G","year":"2007","unstructured":"Monheit G; Carruthers A; Brandt F; Rand R.; A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: Determination of optimal dose. Dermatol Surg  2007,33(1 Spec),S51-S59","journal-title":"Dermatol Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/j.1524-4725.2009.01235.x","volume":"35","author":"Brandt F.","year":"2009","unstructured":"Brandt F.; Swanson N.; Baumann L.; Huber B.; Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: Efficacy and safety. Dermatol Surg  2009,35(12),1893-1901","journal-title":"Dermatol Surg"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.asj.2009.09.003","volume":"29","author":"Cohen J.L.","year":"2009","unstructured":"Cohen J.L.; Schlessinger J.; Cox S.E.; Lin X.; An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesthet Surg J  2009,29(6)(Suppl.),S43-S49","journal-title":"Aesthet Surg J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","volume":"124","author":"Kane M.A.C.","year":"2009","unstructured":"Kane M.A.C.; Brandt F.; Rohrich R.J.; Narins R.S.; Monheit G.D.; Huber M.B.; Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: Results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg  2009,124(5),1619-1629","journal-title":"Plast Reconstr Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/archderm.142.3.320","volume":"142","author":"Rzany B.","year":"2006","unstructured":"Rzany B.; Ascher B.; Fratila A.; Monheit G.D.; Talarico S.; Sterry W.; Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol  2006,142(3),320-326","journal-title":"Arch Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archfaci.2009.5","volume":"11","author":"Moy R.","year":"2009","unstructured":"Moy R.; Maas C.; Monheit G.; Huber M.B.; Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Facial Plast Surg  2009,11(2),77-83","journal-title":"Arch Facial Plast Surg"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1111\/j.1524-4725.2006.32327.x","volume":"33","author":"Rzany B.","year":"2007","unstructured":"Rzany B.; Dill-M\u00fcller D.; Grablowitz D.; Heckmann M.; Caird D.; Repeated botulinum toxin A injections for the treatment of lines in the upper face: A retrospective study of 4,103 treatments in 945 patients. Dermatol Surg  2007,33(s1),S18-S25","journal-title":"Dermatol Surg"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/01676830.2012.736602","volume":"32","author":"Ng S.K.","year":"2013","unstructured":"Ng S.K.; Chan W.; Marcet M.M.; Kakizaki H.; Selva D.; Levator palpebrae superioris: An anatomical update. Orbit  2013,32(1),76-84","journal-title":"Orbit"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/00000637-198504000-00005","volume":"14","author":"Beard C.","year":"1985","unstructured":"Beard C.; M\u00fcller\u2019s superior tarsal muscle: Anatomy, physiology, and clinical significance. Ann Plast Surg  1985,14(4),324-333","journal-title":"Ann Plast Surg"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1111\/jocd.14361","volume":"20","author":"Nestor M.S.","year":"2021","unstructured":"Nestor M.S.; Han H.; Gade A.; Fischer D.; Saban Y.; Polselli R.; Botulinum toxin\u2013induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. J Cosmet Dermatol  2021,20(10),3133-3146","journal-title":"J Cosmet Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1177\/07488068221141813","author":"Turkmani M.G.","year":"2022","unstructured":"Turkmani M.G.; Botulinum toxin treatment for botulinum toxin\u2013induced blepharoptosis. Am J Cosmet Surg  2022","journal-title":"Am J Cosmet Surg"},{"key":"ref=22","author":"Shahzad B.","year":"2022","unstructured":"Shahzad B.; Siccardi M.A.; Ptosis. StatPearls  2022","journal-title":"StatPearls"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1064-7406(03)00070-1","volume":"11","author":"Vartanian A.J.","year":"2003","unstructured":"Vartanian A.J.; Dayan S.H.; Complications of botulinum toxin A use in facial rejuvenation. Facial Plast Surg Clin North Am  2003,11(4),483-492","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41433-021-01547-5","volume":"35","author":"Bacharach J.","year":"2021","unstructured":"Bacharach J.; Lee W.W.; Harrison A.R.; Freddo T.F.; A review of acquired blepharoptosis: Prevalence, diagnosis, and current treatment options. Eye (Lond)  2021,35(9),2468-2481","journal-title":"Eye (Lond)"},{"key":"ref=25","first-page":"E1","volume":"9","author":"King M.","year":"2016","unstructured":"King M.; Management of ptosis. J Clin Aesthet Dermatol  2016,9(12),E1-E4","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000529300","volume":"6","author":"Barut C.","year":"2023","unstructured":"Barut C.; Ogut E.; Askin Z.; Alicikus H.; Branching patterns and variations of facial artery and clinical importance: A cadaveric study. Dubai Med J  2023,6(2),81-96","journal-title":"Dubai Med J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00276-020-02652-y","volume":"43","author":"Ogut E.","year":"2021","unstructured":"Ogut E.; Barut C.; Trifurcation of the facial artery at the inferior border of the mandible: A case report. Surg Radiol Anat  2021,43(3),451-454","journal-title":"Surg Radiol Anat"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.25259\/SNI_597_2023","volume":"14","author":"Kareem Z.M.","year":"2023","unstructured":"Kareem Z.M.; Muthana A.; Hassan S.F.; Ahmed F.O.; Hadi R.T.; Algburi H.A.; Atallah O.; Ismail M.; Hoz S.S.; Supraorbital artery: Anatomical variations and neurosurgical applications. Surg Neurol Int  2023,14,318","journal-title":"Surg Neurol Int"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archopht.123.4.578-a","volume":"123","author":"Brown S.M.","year":"2005","unstructured":"Brown S.M.; The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Arch Ophthalmol  2005,123(4),578-578","journal-title":"Arch Ophthalmol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1055\/s-2008-1035269","volume":"209","author":"Stewart W.C.","year":"1996","unstructured":"Stewart W.C.; Effect and side effects of apraclonidine. Klin Monatsbl Augenheilkd  1996,209(1),A7-A13","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5070\/D306G8W0MC","volume":"11","author":"Scheinfeld N.","year":"2005","unstructured":"Scheinfeld N.; The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face. Dermatol Online J  2005,11(1),9","journal-title":"Dermatol Online J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3928\/1542-8877-19900301-11","volume":"21","author":"Glatt H.J.","year":"1990","unstructured":"Glatt H.J.; Fett D.R.; Putterman A.M.; Comparison of 2.5% and 10% phenylephrine in the elevation of upper eyelids with ptosis. Ophthalmic Surg Lasers Imaging Retina  1990,21(3),173-176","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/DSS.0000000000000967","volume":"43","author":"Mendon\u00e7a T.B.","year":"2017","unstructured":"Mendon\u00e7a T.B.; Lummertz A.P.; Bocaccio F.J.L.; Procianoy F.; Effect of low-concentration, nonmydriatic selective alpha-adrenergic agonist eyedrops on upper eyelid position. Dermatol Surg  2017,43(2),270-274","journal-title":"Dermatol Surg"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5693\/djo.01.2014.07.001","volume":"21","author":"Grace Lee N.","year":"2015","unstructured":"Grace Lee N.; Lin L.W.; Mehta S.; Freitag S.K.; Response to phenylephrine testing in upper eyelids with ptosis. Digit J Ophthalmol  2015,21(3),1-12","journal-title":"Digit J Ophthalmol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.amjsurg.2017.09.015","volume":"214","author":"Cocanour C.S.","year":"2017","unstructured":"Cocanour C.S.; Informed consent\u2014It\u2019s more than a signature on a piece of paper. Am J Surg  2017,214(6),993-997","journal-title":"Am J Surg"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0974-2077.167284","volume":"8","author":"Kapoor L.","year":"2015","unstructured":"Kapoor L.; Informed consent in aesthetic surgery. J Cutan Aesthet Surg  2015,8(3),173-174","journal-title":"J Cutan Aesthet Surg"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00266-008-9246-3","volume":"32","author":"Atiyeh B.S.","year":"2008","unstructured":"Atiyeh B.S.; Rubeiz M.T.; Hayek S.N.; Aesthetic\/Cosmetic surgery and ethical challenges. Aesthetic Plast Surg  2008,32(6),829-839","journal-title":"Aesthetic Plast Surg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0974-2077.167281","volume":"8","author":"Shetty R.","year":"2015","unstructured":"Shetty R.; Outer circle versus inner circle: Special considerations while rejuvenating an Indian face using fillers. J Cutan Aesthet Surg  2015,8(3),169-172","journal-title":"J Cutan Aesthet Surg"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jmwh.2004.01.003","volume":"49","author":"Freda M.C.","year":"2004","unstructured":"Freda M.C.; Issues in patient education. J Midwifery Womens Health  2004,49(3),203-209","journal-title":"J Midwifery Womens Health"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0041-1739250","volume":"54","author":"Sattur S.S.","year":"2021","unstructured":"Sattur S.S.; Sattur I.S.; Patient counselling and medicolegal aspects of hair transplant surgery. Indian J Plast Surg  2021,54(4),441-445","journal-title":"Indian J Plast Surg"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/toxins10010018","volume":"10","author":"Alter K.","year":"2017","unstructured":"Alter K.; Karp B.; Ultrasound guidance for botulinum neurotoxin chemodenervation procedures. Toxins  2017,10(1),18","journal-title":"Toxins"}],"container-title":["Current Reviews in Clinical and Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328310459240809073519","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233152\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724328310459240809073519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T13:36:51Z","timestamp":1733751411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233152\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127724328310459240809073519","relation":{},"ISSN":["2772-4328"],"issn-type":[{"value":"2772-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}